Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results

    Financial Results - Page 8

    Wockhardt Q1 net loss narrows to Rs 86 crore

    Wockhardt Q1 net loss narrows to Rs 86 crore

    Ruby Khatun Khatun6 Aug 2018 10:30 AM IST
    New Delhi: Pharmaceutical firm Wockhardt reported narrowing of its consolidated net loss to Rs 86 crore for the quarter ended June.The company had...
    Torrent Pharma Q1 profit dips 13 percent at Rs 163 crore

    Torrent Pharma Q1 profit dips 13 percent at Rs 163 crore

    Ruby Khatun Khatun5 Aug 2018 10:15 AM IST
    New Delhi: Torrent Pharmaceuticals reported 13.29% decline in its consolidated net profit at Rs 163 crore for the first quarter ended 30 June.The...
    Pfizer lowers 2018 revenue forecast, increases research and development spend

    Pfizer lowers 2018 revenue forecast, increases research and development spend

    Ruby Khatun Khatun2 Aug 2018 9:45 AM IST
    Pfizer Inc lowered its revenue forecast for this year, blaming the stronger dollar, and increased its planned spending on research and development, as...
    AbbVie tops second quarter estimates, sets higher earnings target

    AbbVie tops second quarter estimates, sets higher earnings target

    Ruby Khatun Khatun30 July 2018 9:30 AM IST
    AbbVie Inc on Friday topped Wall Street estimates for second-quarter profit and raised its yearly earnings forecast, led by stronger demand for...
    Sanofi India June quarter net profit up 35 percent to Rs 99.6 crore

    Sanofi India June quarter net profit up 35 percent to Rs 99.6 crore

    Ruby Khatun Khatun29 July 2018 10:30 AM IST
    New Delhi: Drug firm Sanofi India reported a 35.14 percent rise in its net profit to Rs 99.6 crore for the second quarter ended June 30, 2018.The...
    AstraZeneca says second quarter earnings dropped 27 percent

    AstraZeneca says second quarter earnings dropped 27 percent

    Ruby Khatun Khatun29 July 2018 9:45 AM IST
    LONDON: Anglo-Swedish drugmaker AstraZeneca says second-quarter earnings dropped 27 percent as it shifted away from dependence on its former...
    Dr Reddys Labs Q1 net profit increases nearly eight-fold to Rs 456 crore

    Dr Reddy's Labs Q1 net profit increases nearly eight-fold to Rs 456 crore

    Ruby Khatun Khatun28 July 2018 10:30 AM IST
    Hyderabad: Pharma major Dr Reddy's Laboratories reported a nearly eight-fold jump in consolidated profit after tax to Rs 456.1 crore for the first...
    Biocon Q1 net profit up 47 percent to Rs 120 crore

    Biocon Q1 net profit up 47 percent to Rs 120 crore

    Ruby Khatun Khatun28 July 2018 10:15 AM IST
    New Delhi: Biotechnology major Biocon reported a 47 percent rise in its consolidated net profit to Rs 120 crore for the quarter ended June 2018 on...
    GSK Pharma Q1 profit at Rs 88.59 crore

    GSK Pharma Q1 profit at Rs 88.59 crore

    Ruby Khatun Khatun26 July 2018 10:10 AM IST
    New Delhi: GlaxoSmithKline Pharmaceuticals (GSK) reported a standalone net profit of Rs 88.59 crore for the first quarter of the current fiscal.It had...
    Granules India Q1 net profit up 41 percent to Rs 51.7 crore

    Granules India Q1 net profit up 41 percent to Rs 51.7 crore

    Ruby Khatun Khatun25 July 2018 10:00 AM IST
    New Delhi: Drug firm Granules India reported a 40.73 percent rise in its consolidated net profit at Rs 51.79 crore for the quarter ended on June 30,...
    Johnson and Johnsons quarterly profit rises 3.3 percent

    Johnson and Johnson's quarterly profit rises 3.3 percent

    Ruby Khatun Khatun18 July 2018 9:31 AM IST
    Johnson and Johnson reported a 3.3 percent rise in quarterly profit, as higher sales of cancer drugs Zytiga and Darzalex helped offset pressure on its...
    Fortis Healthcare Q4 loss at Rs 914 crore

    Fortis Healthcare Q4 loss at Rs 914 crore

    Ruby Khatun Khatun27 Jun 2018 11:30 AM IST
    New Delhi: Beleaguered Fortis Healthcare today reported widening of its consolidated net loss to Rs 914.32 crore for the fourth quarter ended March...
    PrevNext

    Popular Stories

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cipla Foundation sets up dedicated state-of-the-art chemistry laboratory at IISER Pune

    Cipla Foundation sets up dedicated state-of-the-art chemistry laboratory at IISER Pune

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung...

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok